RedHill Biopharma (RDHL) Shares Outstanding (2011 - 2025)

RedHill Biopharma (RDHL) has 9 years of Shares Outstanding (Entity) data on file, last reported at $901500.0 in Q2 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 53.31% year-over-year to $901500.0 in Q2 2025; TTM through Jun 2025 was $901500.0, a 53.31% increase from a year earlier, with the FY2023 full-year figure at $5.2 million, up 318.41% from the prior year.
• Shares Outstanding (Entity) for Q2 2025 stood at $901500.0, up from $588023.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for RDHL reached as high as $37.4 million in Q3 2021 and fell as low as $588023.0 in Q2 2024.
• Historically, Shares Outstanding (Entity) has averaged $13.7 million across 5 years, with a median of $2.6 million in 2023.
• Across the five-year window, Shares Outstanding (Entity) tumbled 97.07% in 2022 and surged 318.41% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $37.2 million in 2021, then tumbled by 96.67% to $1.2 million in 2022, then jumped by 318.41% to $5.2 million in 2023, then sank by 88.65% to $588023.0 in 2024, then soared by 53.31% to $901500.0 in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $901500.0 in Q2 2025, $588023.0 in Q2 2024, and $5.2 million in Q4 2023.